VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
ASTH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
ASTHAstrana Health, Inc.
$34.91$1.7B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
ASTH logo

Astrana Health, Inc.

ASTH
NASDAQ · Healthcare Facilities
$34.91
At close - Oct 1, 4:00 PM EDT - USD
Market Cap$1.73B
P/E75.9x
52W High$51.60
Volume266.69K
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q2

Revenue Surge Masks Thin Margins and Rising Leverage

Astrana Health is executing an aggressive acquisition-led growth strategy, with revenue up 48.5% YoY to $972.5M in 2026Q2, but this expansion is straining profitability and the balance sheet. Gross margin compressed to 10.7% from 11.9% a year earlier, and net ...

GrowthAccelerating
ProfitabilityStrained
ValuationAttractive
TechnicalsMixed
Explore valuation models
MARKET ACTION

ASTH price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

7/12 Beats

EPS beat 7 of last 12 quarters

02

Valuation risk

+97% Peers

P/E is 97% above peer median

03

Market leadership

RS 74 · Avg

Average momentum (RS Rating: 74)

04

Mixed Trend

Mixed

Price < 50DMA but > 200DMA

Next CatalystEstimated earnings · Nov 6

Market performance

Price History →

Trailing total returns as of 10/2/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
ASTH+38.42%
S&P 500 (^GSPC)+11.83%
1-Year Return
ASTH+23.97%
S&P 500 (^GSPC)+14.29%
3-Year Return
ASTH+14.05%
S&P 500 (^GSPC)+75.91%
5-Year Return
ASTH-60.96%
S&P 500 (^GSPC)+75.85%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/E5Y High
75.9x
Forward P/EExpansion
25.0x
EV/EBITDA80th %ile
19.1x
FCF YieldCash Flow
6.0%

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
75.9x
35.0x
100th· High
EV/EBITDA
19.1x
15.1x
80th· High
Price/FCF
16.6x
34.4x
20th· Low
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
Bear$0.19-99.5%
Base (Fair)$39.60+8.9%
Bull$18.19-47.9%
$0.19 Bear$39.60 Base$18.19 Bull
Current Market Price: $34.91
Trades at a 11.8% discount to Base DCF ($39.60)
Open DCF & Valuation Models →Chart Terminal ↗

Growth & profitability

Annual revenue & EPS trend
Revenue
$3.18B+56.4% YoY
Net income
$22M-47.9% YoY
Free cash flow
$104M+136.6% YoY
Operating margin
2.5%-1.9 pts YoY
ROIC (TTM)6.2%
Avg ROIC 5Y-
ROE (TTM)4.2%
Piotroski Score3 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate7/12 (58%)
Revenue Beat Rate6/12 (50%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q3 2026Latest
Aug 6, 2026
$0.40+19.1%
vs $0.34
$973M-1.0%
vs $982M
Q2 2026
May 7, 2026
$0.30+3.4%
vs $0.29
$965M+1.7%
vs $949M
Q2 2026
Mar 2, 2026
$0.12-20.0%
vs $0.15
$951M+2.2%
vs $930M
Q4 2025
Nov 6, 2025
$0.01-97.9%
vs $0.47
$956M+2.7%
vs $930M
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

5 Stories
Business Wire·Sep 25, 2026
PRIVACY ALERT: AWKO Law Investigating Astrana Health Data Breach

SAN FRANCISCO--(BUSINESS WIRE)--AWKO Law LLP is investigating a data breach that led to unauthorized access to the sensitive information of individuals affiliated with Astrana Health, Inc.'s subsidiary, Astrana Health Management, Inc. Astrana Health, Inc. is a California-based technology-powered healthcare company that operates as a Management Services Organization (MSO). On September 23, 2026, Astrana Health, Inc. disclosed to the Securities and Exchange Commission (“SEC”) that unauthorized ac.

GlobeNewsWire·Sep 22, 2026
Lowey Dannenberg, P.C. is Investigating Astrana Health, Inc. (NASDAQ: ASTH) for Potential Violations of the Federal Securities Laws

NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C.

Seeking Alpha·Aug 12, 2026
Astrana Health: 81% Full-Risk And Profitable

Astrana Health is rated a buy, trading at a 46% discount to peers despite sector-wide reserve releases clarifying earnings quality concerns. ASTH's Care Enablement platform drove G&A costs from 7.75% to 5.57% of revenue, quadrupling third-party revenue year-over-year and supporting durable profit at scale. Organic growth is driven by a mix-shift into full-risk capitation, with management projecting ongoing revenue-per-member expansion and a robust conversion pipeline.

Seeking Alpha·Aug 7, 2026
Astrana Health, Inc. (ASTH) Q2 2026 Earnings Call Transcript

Astrana Health, Inc. (ASTH) Q2 2026 Earnings Call Transcript

Filtered for Astrana Health, Inc.More Headlines
04

Compare before deciding

Benchmark ASTH against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for Astrana Health, Inc. (ASTH)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
ASTH logoASTHAstrana Health, Inc.Current
$34.91$1.73B75.8956.39%0.71%4.19%0.46%
ALHC logoALHCAlignment Healthcare, Inc.
$7.74$1.6B-2091.8946.06%0.89%20.02%—
CLOV logoCLOVClover Health Investments, Corp.
$4.23$2.19B-24.8840.34%-0.74%-5.38%—
OSCR logoOSCROscar Health, Inc.
$29.90$7.75B-17.6927.5%3.6%38.45%—
WELL logoWELLWelltower Inc.
$227.20$163.71B163.4535.82%10.67%3.08%—
AGL logoAGLAgilon Health, Inc.
$82.28$1.37B-3.36-2.11%-4.24%-119.35%—

Compare ASTH vs Peers

Astrana Health, Inc. (ASTH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ALHC

Most directly comparable listed peer for ASTH.

Scale Benchmark

vs UNH

Larger-name benchmark to compare ASTH against a more recognizable public peer.

Peer Set

Compare Top 5

vs ALHC, CLOV, OSCR, WELL

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

ASTH SEC Filings & Documents

Astrana Health, Inc. (ASTH) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Aug 6, 2026·SEC

Material company update

Jul 13, 2026·SEC

Material company update

Jul 1, 2026·SEC

10-K Annual Reports

2
FY 2026

Mar 12, 2026·SEC

FY 2025

Mar 14, 2025·SEC

10-Q Quarterly Reports

6
FY 2026

Aug 10, 2026·SEC

FY 2026

May 8, 2026·SEC

FY 2025

Nov 10, 2025·SEC

Get notified when ASTH posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

ASTH Frequently Asked Questions

Astrana Health, Inc. (ASTH) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Astrana Health, Inc.'s revenue?

Astrana Health, Inc. (ASTH) reported $3.84B in revenue for fiscal year 2025. This represents a 8627% increase from $44.0M in 2015.

How fast is Astrana Health, Inc. growing?

Astrana Health, Inc. (ASTH) grew revenue by 56.4% over the past year. This is strong growth.

Is ASTH profitable?

Yes, Astrana Health, Inc. (ASTH) is profitable, generating $40.5M in net income for fiscal year 2025 (0.7% net margin).

Dividend & Returns
Does ASTH pay dividends?

Yes, Astrana Health, Inc. (ASTH) pays a dividend with a yield of 0.46%. This makes it attractive for income-focused investors.

What is ASTH's return on equity?

Astrana Health, Inc. (ASTH) has a return on equity (ROE) of 4.2%. This is below average, suggesting room for improvement.

What is Astrana Health, Inc.'s free cash flow?

Astrana Health, Inc. (ASTH) generated $158.4M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in ASTH back in 2015?

Total return calculator · dividends reinvested · 11+ years of data

See returns →